APO Research
Talk to an analyst

APO RESEARCH · REPORT

Subcutaneous Allergy Immunotherapies

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Subcutaneous Allergy Immunotherapies Industry Growth and Trends Forecast to 2032

19 December 202597 pages

Choose your research edition.

Industry ResearchSubcutaneous Allergy Immunotherapies Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Subcutaneous Allergy Immunotherapies Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Subcutaneous Allergy Immunotherapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Subcutaneous Allergy Immunotherapies Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Subcutaneous Allergy Immunotherapies Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Subcutaneous Allergy Immunotherapies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Subcutaneous Allergy Immunotherapies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Subcutaneous Allergy Immunotherapies is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Subcutaneous Allergy Immunotherapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Subcutaneous Allergy Immunotherapies include Merck, WOLW Pharma, Stallergenes Greer, Leti, Holister Stier, HAL, Allergy Therapeutics and ALK-Abello, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Subcutaneous Allergy Immunotherapies market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Subcutaneous Allergy Immunotherapies market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Subcutaneous Allergy Immunotherapies market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Subcutaneous Allergy Immunotherapies.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Subcutaneous Allergy Immunotherapies market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Subcutaneous Allergy Immunotherapies Market by Company

Merck

WOLW Pharma

Stallergenes Greer

Leti

Holister Stier

HAL

Allergy Therapeutics

ALK-Abello

Subcutaneous Allergy Immunotherapies Segment by Type

High Concentration

Low Concentration

Subcutaneous Allergy Immunotherapies Segment by Application

Primary Immunodeficiency

Secondary Immunodeficiency

Others

Subcutaneous Allergy Immunotherapies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Subcutaneous Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Subcutaneous Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Subcutaneous Allergy Immunotherapies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Subcutaneous Allergy Immunotherapies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Subcutaneous Allergy Immunotherapies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of High Concentration Table 2. Major Company of Low Concentration Table 3. Global Subcutaneous Allergy Immunotherapies Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (K Units) Table 5. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Type (2021-2026) Table 6. Global Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (US$ Million) Table 7. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Type (2021-2026) Table 8. Global Subcutaneous Allergy Immunotherapies Price by Type (2021-2026) & (US$/Unit) Table 9. Global Subcutaneous Allergy Immunotherapies Sales by Type (2027-2032) & (K Units) Table 10. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Type (2027-2032) Table 11. Global Subcutaneous Allergy Immunotherapies Sales by Type (2027-2032) & (US$ Million) Table 12. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Type (2027-2032) Table 13. Global Subcutaneous Allergy Immunotherapies Price by Type (2027-2032) & (US$/Unit) Table 14. North America Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (K Units) Table 15. North America Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (K Units) Table 17. Europe Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (K Units) Table 21. Latin America Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Type (2021-2026) & (US$ Million) Table 24. Subcutaneous Allergy Immunotherapies Industry Trends Table 25. Subcutaneous Allergy Immunotherapies Industry Drivers Table 26. Subcutaneous Allergy Immunotherapies Industry Opportunities and Challenges Table 27. Subcutaneous Allergy Immunotherapies Industry Restraints Table 28. Global Subcutaneous Allergy Immunotherapies Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Company (2021-2026) Table 30. Global Subcutaneous Allergy Immunotherapies Sales by Company (2021-2026) & (K Units) Table 31. Global Subcutaneous Allergy Immunotherapies Sales Share by Company (2021-2026) Table 32. Global Subcutaneous Allergy Immunotherapies Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Subcutaneous Allergy Immunotherapies Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Subcutaneous Allergy Immunotherapies Major Company Production Sites and Headquarters Table 35. Global Subcutaneous Allergy Immunotherapies Company, Product Type & Application Table 36. Global Subcutaneous Allergy Immunotherapies Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Subcutaneous Allergy Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Subcutaneous Allergy Immunotherapies Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Subcutaneous Allergy Immunotherapies Sales by Region (2021-2026) & (K Units) Table 41. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Region (2021-2026) Table 42. Global Subcutaneous Allergy Immunotherapies Sales by Region (2021-2026) & (US$ Million) Table 43. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Region (2021-2026) Table 44. Global Subcutaneous Allergy Immunotherapies Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Subcutaneous Allergy Immunotherapies Sales by Region (2027-2032) & (K Units) Table 46. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Region (2027-2032) Table 47. Global Subcutaneous Allergy Immunotherapies Sales by Region (2027-2032) & (US$ Million) Table 48. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Region (2027-2032) Table 49. Global Subcutaneous Allergy Immunotherapies Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Subcutaneous Allergy Immunotherapies Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (K Units) Table 52. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Application (2021-2026) Table 53. Global Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (US$ Million) Table 54. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Application (2021-2026) Table 55. Global Subcutaneous Allergy Immunotherapies Price by Application (2021-2026) & (US$/Unit) Table 56. Global Subcutaneous Allergy Immunotherapies Sales by Application (2027-2032) & (K Units) Table 57. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Application (2027-2032) Table 58. Global Subcutaneous Allergy Immunotherapies Sales by Application (2027-2032) & (US$ Million) Table 59. Global Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Application (2027-2032) Table 60. Global Subcutaneous Allergy Immunotherapies Price by Application (2027-2032) & (US$/Unit) Table 61. North America Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (K Units) Table 62. North America Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (K Units) Table 64. Europe Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (K Units) Table 68. Latin America Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Subcutaneous Allergy Immunotherapies Product Portfolio Table 75. Merck Recent Development Table 76. WOLW Pharma Company Information Table 77. WOLW Pharma Business Overview Table 78. WOLW Pharma Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolio Table 80. WOLW Pharma Recent Development Table 81. Stallergenes Greer Company Information Table 82. Stallergenes Greer Business Overview Table 83. Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolio Table 85. Stallergenes Greer Recent Development Table 86. Leti Company Information Table 87. Leti Business Overview Table 88. Leti Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Leti Subcutaneous Allergy Immunotherapies Product Portfolio Table 90. Leti Recent Development Table 91. Holister Stier Company Information Table 92. Holister Stier Business Overview Table 93. Holister Stier Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolio Table 95. Holister Stier Recent Development Table 96. HAL Company Information Table 97. HAL Business Overview Table 98. HAL Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. HAL Subcutaneous Allergy Immunotherapies Product Portfolio Table 100. HAL Recent Development Table 101. Allergy Therapeutics Company Information Table 102. Allergy Therapeutics Business Overview Table 103. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolio Table 105. Allergy Therapeutics Recent Development Table 106. ALK-Abello Company Information Table 107. ALK-Abello Business Overview Table 108. ALK-Abello Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolio Table 110. ALK-Abello Recent Development Table 111. North America Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026) & (K Units) Table 113. North America Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2021-2026) Table 114. North America Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Subcutaneous Allergy Immunotherapies Sales Market Share Forecast by Country (2027-2032) Table 116. North America Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Subcutaneous Allergy Immunotherapies Market Share by Country (2021-2026) Table 119. North America Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Subcutaneous Allergy Immunotherapies Market Share Forecast by Country (2027-2032) Table 121. Europe Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026) & (K Units) Table 123. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2021-2026) Table 124. Europe Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Subcutaneous Allergy Immunotherapies Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Subcutaneous Allergy Immunotherapies Market Share by Country (2021-2026) Table 129. Europe Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Subcutaneous Allergy Immunotherapies Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Subcutaneous Allergy Immunotherapies Market Share by Country (2021-2026) Table 139. Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Subcutaneous Allergy Immunotherapies Market Share Forecast by Country (2027-2032) Table 141. Latin America Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026) & (K Units) Table 143. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2021-2026) Table 144. Latin America Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Subcutaneous Allergy Immunotherapies Market Share by Country (2021-2026) Table 149. Latin America Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Subcutaneous Allergy Immunotherapies Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Subcutaneous Allergy Immunotherapies Market Share by Country (2021-2026) Table 159. Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Subcutaneous Allergy Immunotherapies Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Subcutaneous Allergy Immunotherapies Distributors List Table 164. Subcutaneous Allergy Immunotherapies Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Subcutaneous Allergy Immunotherapies Image Figure 2. Global Subcutaneous Allergy Immunotherapies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Subcutaneous Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 4. Global Subcutaneous Allergy Immunotherapies Sales (2021-2032) & (K Units) Figure 5. High Concentration Image Figure 6. Global High Concentration Sales YoY Growth (2021-2032) & (K Units) Figure 7. Low Concentration Image Figure 8. Global Low Concentration Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Subcutaneous Allergy Immunotherapies Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Subcutaneous Allergy Immunotherapies Market Share by Type 2025 VS 2032 Figure 11. North America Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Type in 2025 Figure 12. North America Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Type in 2025 Figure 13. Europe Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Type in 2025 Figure 14. Europe Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Type in 2025 Figure 17. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Subcutaneous Allergy Immunotherapies Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Primary Immunodeficiency Image Figure 24. Global Primary Immunodeficiency Sales YoY Growth (2021-2032) & (K Units) Figure 25. Secondary Immunodeficiency Image Figure 26. Global Secondary Immunodeficiency Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Subcutaneous Allergy Immunotherapies Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Subcutaneous Allergy Immunotherapies Market Share by Application 2025 VS 2032 Figure 31. North America Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Application in 2025 Figure 32. North America Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Application in 2025 Figure 33. Europe Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Application in 2025 Figure 34. Europe Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Application in 2025 Figure 37. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share in Value by Application in 2025 Figure 41. North America Subcutaneous Allergy Immunotherapies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Subcutaneous Allergy Immunotherapies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Subcutaneous Allergy Immunotherapies Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Subcutaneous Allergy Immunotherapies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Subcutaneous Allergy Immunotherapies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Subcutaneous Allergy Immunotherapies Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Subcutaneous Allergy Immunotherapies Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Subcutaneous Allergy Immunotherapies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Subcutaneous Allergy Immunotherapies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Subcutaneous Allergy Immunotherapies Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Subcutaneous Allergy Immunotherapies Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Subcutaneous Allergy Immunotherapies Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Subcutaneous Allergy Immunotherapies Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • High Concentration
  • Low Concentration
Applications
  • Primary Immunodeficiency
  • Secondary Immunodeficiency
  • Others
Companies covered
  • Merck
  • WOLW Pharma
  • Stallergenes Greer
  • Leti
  • Holister Stier
  • HAL
  • Allergy Therapeutics
  • ALK-Abello

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Subcutaneous Allergy Immunotherapies Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Subcutaneous Allergy Immunotherapies Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Subcutaneous Allergy Immunotherapies Market by Type
  6. 1.3.1 High Concentration
  7. 1.3.2 Low Concentration
  8. 1.4 Global Subcutaneous Allergy Immunotherapies Market Size by Type
  9. 1.4.1 Global Subcutaneous Allergy Immunotherapies Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Subcutaneous Allergy Immunotherapies Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Subcutaneous Allergy Immunotherapies Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Subcutaneous Allergy Immunotherapies Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Subcutaneous Allergy Immunotherapies Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Subcutaneous Allergy Immunotherapies Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Subcutaneous Allergy Immunotherapies Industry Trends
  2. 2.2 Subcutaneous Allergy Immunotherapies Industry Drivers
  3. 2.3 Subcutaneous Allergy Immunotherapies Industry Opportunities and Challenges
  4. 2.4 Subcutaneous Allergy Immunotherapies Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Subcutaneous Allergy Immunotherapies Revenue (2021-2026)
  2. 3.2 Global Top Players by Subcutaneous Allergy Immunotherapies Sales (2021-2026)
  3. 3.3 Global Top Players by Subcutaneous Allergy Immunotherapies Price (2021-2026)
  4. 3.4 Global Subcutaneous Allergy Immunotherapies Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Subcutaneous Allergy Immunotherapies Major Company Production Sites & Headquarters
  6. 3.6 Global Subcutaneous Allergy Immunotherapies Company, Product Type & Application
  7. 3.7 Global Subcutaneous Allergy Immunotherapies Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Subcutaneous Allergy Immunotherapies Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Subcutaneous Allergy Immunotherapies Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Subcutaneous Allergy Immunotherapies Tier 1, Tier 2, and Tier 3
4 Subcutaneous Allergy Immunotherapies Regional Status and Outlook
  1. 4.1 Global Subcutaneous Allergy Immunotherapies Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Subcutaneous Allergy Immunotherapies Historic Market Size by Region
  3. 4.2.1 Global Subcutaneous Allergy Immunotherapies Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Subcutaneous Allergy Immunotherapies Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Subcutaneous Allergy Immunotherapies Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Subcutaneous Allergy Immunotherapies Forecasted Market Size by Region
  7. 4.3.1 Global Subcutaneous Allergy Immunotherapies Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Subcutaneous Allergy Immunotherapies Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Subcutaneous Allergy Immunotherapies Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Subcutaneous Allergy Immunotherapies by Application
  1. 5.1 Subcutaneous Allergy Immunotherapies Market by Application
  2. 5.1.1 Primary Immunodeficiency
  3. 5.1.2 Secondary Immunodeficiency
  4. 5.1.3 Others
  5. 5.2 Global Subcutaneous Allergy Immunotherapies Market Size by Application
  6. 5.2.1 Global Subcutaneous Allergy Immunotherapies Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Subcutaneous Allergy Immunotherapies Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Subcutaneous Allergy Immunotherapies Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Subcutaneous Allergy Immunotherapies Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Subcutaneous Allergy Immunotherapies Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Subcutaneous Allergy Immunotherapies Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Subcutaneous Allergy Immunotherapies Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 WOLW Pharma
  8. 6.2.1 WOLW Pharma Company Information
  9. 6.2.2 WOLW Pharma Business Overview
  10. 6.2.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolio
  12. 6.2.5 WOLW Pharma Recent Developments
  13. 6.3 Stallergenes Greer
  14. 6.3.1 Stallergenes Greer Company Information
  15. 6.3.2 Stallergenes Greer Business Overview
  16. 6.3.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolio
  18. 6.3.5 Stallergenes Greer Recent Developments
  19. 6.4 Leti
  20. 6.4.1 Leti Company Information
  21. 6.4.2 Leti Business Overview
  22. 6.4.3 Leti Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Leti Subcutaneous Allergy Immunotherapies Product Portfolio
  24. 6.4.5 Leti Recent Developments
  25. 6.5 Holister Stier
  26. 6.5.1 Holister Stier Company Information
  27. 6.5.2 Holister Stier Business Overview
  28. 6.5.3 Holister Stier Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolio
  30. 6.5.5 Holister Stier Recent Developments
  31. 6.6 HAL
  32. 6.6.1 HAL Company Information
  33. 6.6.2 HAL Business Overview
  34. 6.6.3 HAL Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HAL Subcutaneous Allergy Immunotherapies Product Portfolio
  36. 6.6.5 HAL Recent Developments
  37. 6.7 Allergy Therapeutics
  38. 6.7.1 Allergy Therapeutics Company Information
  39. 6.7.2 Allergy Therapeutics Business Overview
  40. 6.7.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolio
  42. 6.7.5 Allergy Therapeutics Recent Developments
  43. 6.8 ALK-Abello
  44. 6.8.1 ALK-Abello Company Information
  45. 6.8.2 ALK-Abello Business Overview
  46. 6.8.3 ALK-Abello Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolio
  48. 6.8.5 ALK-Abello Recent Developments
7 North America by Country
  1. 7.1 North America Subcutaneous Allergy Immunotherapies Sales by Country
  2. 7.1.1 North America Subcutaneous Allergy Immunotherapies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026)
  4. 7.1.3 North America Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032)
  5. 7.2 North America Subcutaneous Allergy Immunotherapies Market Size by Country
  6. 7.2.1 North America Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026)
  8. 7.2.3 North America Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Subcutaneous Allergy Immunotherapies Sales by Country
  2. 8.1.1 Europe Subcutaneous Allergy Immunotherapies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026)
  4. 8.1.3 Europe Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Subcutaneous Allergy Immunotherapies Market Size by Country
  6. 8.2.1 Europe Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026)
  8. 8.2.3 Europe Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Subcutaneous Allergy Immunotherapies Sales by Country
  2. 9.1.1 Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size by Country
  6. 9.2.1 Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Subcutaneous Allergy Immunotherapies Sales by Country
  2. 10.1.1 South America Subcutaneous Allergy Immunotherapies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026)
  4. 10.1.3 South America Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032)
  5. 10.2 South America Subcutaneous Allergy Immunotherapies Market Size by Country
  6. 10.2.1 South America Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026)
  8. 10.2.3 South America Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country
  2. 11.1.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Country
  6. 11.2.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Subcutaneous Allergy Immunotherapies Value Chain Analysis
  2. 12.1.1 Subcutaneous Allergy Immunotherapies Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Subcutaneous Allergy Immunotherapies Production Mode & Process
  7. 12.2 Subcutaneous Allergy Immunotherapies Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Subcutaneous Allergy Immunotherapies Distributors
  10. 12.2.3 Subcutaneous Allergy Immunotherapies Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst